Paul Maeder News
Most Popular Paul Maeder Story
Rocky market puts freeze on biotech deal-making
Turmoil on the Street has created a bleak financial landscape for emerging biotech companies. Only four biotech and medical device firms backed by venture capital outfits went public in the first Read more...
Latest Headlines
- April 2, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
